ArticleScientific reports2025
Preserved white matter integrity is a promising indicator of cognitive resilience in Parkinson's disease.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Cognitive and motor impairment in Parkinson’s disease (PD) is linked to white matter integrity, yet the prognostic utility of white matter-derived imaging metrics for predicting cognitive and motor decline remains underexplored. Leveraging longitudinal clinical and neuroimaging data from the Parkinson’s Progression Markers Initiative (PPMI) cohort, this study identified microstructural integrity of several specific white matter tracts, including corpus callosum (body, genu, and splenium) and right inferior cerebellar peduncle, as potential indicators for longitudinal cognitive decline in PD patients. Specifically, over a mean follow-up period of 49.13 months, reduced integrity in these tracts was linked to accelerated cognitive decline, while preserved integrity was associated with slower cognitive decline. In contrast, no white matter-based imaging metrics demonstrated significant associations with motor decline after corrections for multiple testing. These findings underscore the critical role of white matter integrity as a potential indicator for tracking longitudinal cognitive deterioration in PD. By pinpointing specific white matter alterations linked to cognitive progression, this study offers valuable insights into the neural substrates of cognitive deficits in PD. Future research should focus on elucidating the molecular mechanisms underlying the relationship between white matter integrity and cognitive function, potentially informing targeted therapeutic strategies to mitigate cognitive impairment and enhance quality of life for PD patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.